SCHEMBL6465657

SCHEMBL6465657

CC(C)=C1Oc2cccc(OCCCN3CCC(NC(=O)c4cccs4)CC3)c2C1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.57
DRD2 P14416 10/20 0.45
DRD3 P35462 10/20 0.45
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
POLB P06746 1/20 0.40
UTS2R Q9UKP6 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6457124 0.87 ADRA1D (0.50) HTR7DRD2DRD3ADRA1DADRA1A
SCHEMBL6462987 0.86 HTR7 (0.47) HTR7ADRA1DADRA1AADRA1BPOLB
SCHEMBL6466592 0.86 HTR7 (0.55) HTR7DRD2DRD3ADRA1DADRA1A
SCHEMBL6461236 0.85 HTR7 (0.46) HTR7ADRA1DADRA1AADRA1BPOLB
SCHEMBL6463130 0.85 POLB (0.51) HTR7DRD3POLBMEN1ALDH1A1
SCHEMBL6457611 0.84 SLC6A5 (0.51) HTR7DRD2DRD3
SCHEMBL6462598 0.84 HTR7 (0.54) HTR7DRD2DRD3ADRA1DADRA1A
SCHEMBL6458101 0.84 HTR7 (0.54) HTR7DRD2DRD3ADRA1DADRA1A
SCHEMBL6462625 0.83 SIGMAR1 (0.52) DRD2ADRA1AADRA1B
SCHEMBL6467624 0.83 HRH2 (0.55) HTR7DRD2DRD3ADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1012147-B1 O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS HOFFMANN LA ROCHE (CH) 2005-11-02 EP disclosed
US-6200989-B1 ADMINISTERING AS UROKINASE PLASMINOGEN ACTIVATOR ANTAGONISTS, ANTITUMOR AND ANTIMETASTASIS AGENTS HOFFMANN-LA ROCHE INC. 2001-03-13 US disclosed